Advanced search
Publication Cover
Medical Mycology Volume 50, 2012 - Issue 5
Submit an article Journal homepage
358
Views
3
CrossRef citations to date
0
Altmetric
Rapid Communication

Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis

Dimitris A. Tsitsikas *Department of Haematological Oncology, St Bartholomew's Hospital, London
,
Amelie Morin *Department of Haematological Oncology, St Bartholomew's Hospital, London
,
Shamzah Araf *Department of Haematological Oncology, St Bartholomew's Hospital, London
,
Bernadine Murtagh *Department of Haematological Oncology, St Bartholomew's Hospital, London
,
Gemma Johnson †Blizzard Institute of Cellular and Molecular Science, Queen Mary University, London
,
Sarah Vinnicombe ‡Department of Diagnostic Imaging Barts and the London NHS Trust
,
Stephen Ellis ‡Department of Diagnostic Imaging Barts and the London NHS Trust
,
Tamara Suaris ‡Department of Diagnostic Imaging Barts and the London NHS Trust
,
Mark Wilks †Blizzard Institute of Cellular and Molecular Science, Queen Mary University, London
,
Sarah Doffman §Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
&
Samir G. Agrawal *Department of Haematological Oncology, St Bartholomew's Hospital, London; †Blizzard Institute of Cellular and Molecular Science, Queen Mary University, LondonCorrespondence[email protected]
 show all
Pages 538-542 | Received 19 May 2011, Accepted 03 Oct 2011, Published online: 10 Nov 2011

References

  • Girmenia C, Barosi G, Aversa F, . Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Clin Infect Dis 2009; 49: 1226–1236.
  • Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis 2008; 15: 1041–1050.
  • Pagano L, Caira M, Picardi M, . Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality – SEIFEM-C Report. Clin Infect Dis 2007; 1: 1524–1525.
  • Pagano L, Caira M, Candoni A, . Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. Haematologica 2010; 95: 644–650.
  • von Eiff M, Roos N, Schulten R, . Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995; 62: 341–347.
  • Ostrosky-Zeichner L, Alexander BD, Kett DH, . Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41: 654–659.
  • Kawazu M, Kanda Y, Nannya Y, . Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004; 42: 2733–2741.
  • Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42: 1417–1427.
  • Leeflang MM, Debets-Ossenkopp YJ, Visser CE, . Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database Syst Rev 2008; 8: CD007394.
  • Mengoli C, Cruciani M, Barnes RA, . Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 89–96.
  • Sinkó J, Csomor J, Nikolova R, . Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey. Transpl Infect Dis 2008; 10: 106–109.
  • Chamilos G, Luna M, Lewis RE, . Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003). Haematologica 2006; 91: 986–989.
  • Ascioglu S, Rex JH, de Pauw B, . Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14.
  • De Pauw B, Walsh TJ, Donnelly JP, . European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813–1821.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.